LeenLife Pharma International: Corporate Updates

May 18, 2016 – CSE – LLP Vancouver, B.C. – LeenLife Pharma International Inc. (the “Company”) is pleased to announce the appointment of several professional advisors and consultants to support the management team and the buildup of the LeenLife products.... read more

Closing of Transaction to Acquire Ninety Percent of Leenlife Pharma S.A.

February 25, 2016 CSE – LLP
Vancouver, B.C. – LeenLife Pharma International Inc. (the “Company”) is pleased to announce that it has now completed the acquisition of a 90% interest in LeenLife Pharma S.A., a private Polish company, which has developed a process for the isolation of Omega 3 fatty acids from flax seeds. In its news release dated December 2, 2015, the Company announced that it had received final approval from the Canadian Securities Exchange (the “CSE”) for the acquisition and proceeded with a change of its name to LeenLife Pharma International Inc. in anticipation of closing the transaction. Due to unforeseen issues with the vendor and the process for completing the share transfer in Poland, which required attendance of signing officers before a notary public in Poland, to have documents properly sworn for filing, the Company was not able to complete the transaction until February 18, 2016.

read more

Conditional Approval to Acquire LeenLIfe Pharma

November 3, 2015   The Canadian Securities Exchange (“CSE”) has given conditional approval for the Company to acquire a 90% interest in LeenLife Pharma S.A. and resume trading. Pursuant to the acquisition of LeenLife Pharma S.A., the Company was required to file a... read more

SPT ACQUIRES 90% of LEENLIFE PHARMA S.A.

July 8, 2015   The Company reports that it has entered into a Share Purchase Agreement to acquire a 90% interest in a Polish private company, LeenLife Pharma S.A. (hereinafter referred to as “LeenLife”), which has developed a process to isolate Omega 3 fatty acids... read more